Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 3
2010 1
2011 3
2012 2
2013 3
2014 3
2015 3
2016 5
2017 4
2018 4
2019 1
2020 4
2021 11
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Results by year
Filters applied: . Clear all
Page 1
Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus.
Ostendorf L, Burns M, Durek P, Heinz GA, Heinrich F, Garantziotis P, Enghard P, Richter U, Biesen R, Schneider U, Knebel F, Burmester G, Radbruch A, Mei HE, Mashreghi MF, Hiepe F, Alexander T. Ostendorf L, et al. Among authors: biesen r. N Engl J Med. 2020 Sep 17;383(12):1149-1155. doi: 10.1056/NEJMoa2023325. N Engl J Med. 2020. PMID: 32937047
Granulomatous large vessel phlebitis in sarcoidosis.
Biesen R, Lerchbaumer M, Frese JP, Schaumburg D, Dölling M, Kleinschmidt MC, Burmester GR, Furth C, Stenzel W, Schneider U. Biesen R, et al. Rheumatology (Oxford). 2021 Dec 1;60(12):e432-e434. doi: 10.1093/rheumatology/keab519. Rheumatology (Oxford). 2021. PMID: 34175925 No abstract available.
[DNA microarrays].
Biesen R, Häupl T. Biesen R, et al. Z Rheumatol. 2011 Nov;70(9):803-6, 808. doi: 10.1007/s00393-011-0869-4. Z Rheumatol. 2011. PMID: 21956826 German.
Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus.
Zorn-Pauly L, von Stuckrad ASL, Klotsche J, Rose T, Kallinich T, Enghard P, Ostendorf L, Burns M, Doerner T, Meisel C, Schneider U, Unterwalder N, Burmester G, Hiepe F, Alexander T, Biesen R. Zorn-Pauly L, et al. Among authors: biesen r. Rheumatology (Oxford). 2021 Nov 27:keab875. doi: 10.1093/rheumatology/keab875. Online ahead of print. Rheumatology (Oxford). 2021. PMID: 34849605
[Systemic lupus erythematosus. Target criteria for treatment].
Alexander T, Biesen R, Jacobi A, Hoyer B, Bruns A, Hiepe F. Alexander T, et al. Among authors: biesen r. Z Rheumatol. 2009 Feb;68(1):23-9. doi: 10.1007/s00393-008-0359-5. Z Rheumatol. 2009. PMID: 19145446 Review. German.
CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity.
Doehn JM, Tabeling C, Biesen R, Saccomanno J, Madlung E, Pappe E, Gabriel F, Kurth F, Meisel C, Corman VM, Hanitsch LG, Treskatsch S, Heim K, Stegemann MS, Ruwwe-Glösenkamp C, Müller-Redetzky HC, Uhrig A, Somasundaram R, Spies C, von Bernuth H, Hofmann J, Drosten C, Suttorp N, Witzenrath M, Sander LE, Hübner RH. Doehn JM, et al. Among authors: biesen r. Infection. 2021 Aug;49(4):757-762. doi: 10.1007/s15010-021-01606-9. Epub 2021 Apr 6. Infection. 2021. PMID: 33825125 Free PMC article.
Nuclear antigen-reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys.
Abdirama D, Tesch S, Grießbach AS, von Spee-Mayer C, Humrich JY, Stervbo U, Babel N, Meisel C, Alexander T, Biesen R, Bacher P, Scheffold A, Eckardt KU, Hiepe F, Radbruch A, Burmester GR, Riemekasten G, Enghard P. Abdirama D, et al. Among authors: biesen r. Kidney Int. 2021 Jan;99(1):238-246. doi: 10.1016/j.kint.2020.05.051. Epub 2020 Jun 24. Kidney Int. 2021. PMID: 32592813 Free article.
44 results